Unity Biotechnology Stock Price History
| UBX Stock | USD 1.83 0.13 7.65% |
Below is the normalized historical share price chart for Unity Biotechnology extending back to May 03, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Unity Biotechnology stands at 1.83, as last reported on the 22nd of March, with the highest price reaching 1.85 and the lowest price hitting 1.69 during the day.
If you're considering investing in Unity Stock, it is important to understand the factors that can impact its price. Unity Biotechnology is dangerous given 3 months investment horizon. Unity Biotechnology owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.15, which indicates the firm had a 0.15 % return per unit of risk over the last 3 months. We have analyzed twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.45% are justified by taking the suggested risk. Use Unity Biotechnology Semi Deviation of 5.96, risk adjusted performance of 0.1117, and Coefficient Of Variation of 864.17 to evaluate company specific risk that cannot be diversified away.
At this time, Unity Biotechnology's Common Stock Shares Outstanding is fairly stable compared to the past year. Common Stock is likely to rise to 2,578 in 2025, whereas Total Stockholder Equity is likely to drop slightly above 6.2 M in 2025. . At this time, Unity Biotechnology's Price To Sales Ratio is fairly stable compared to the past year. Price Book Value Ratio is likely to rise to 2.66 in 2025, whereas Price Earnings Ratio is likely to drop (0.66) in 2025. Unity Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 3rd of May 2018 | 200 Day MA 1.5046 | 50 Day MA 1.9039 | Beta 1.025 |
Unity |
Sharpe Ratio = 0.1478
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | UBX | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 9.82 actual daily | 87 87% of assets are less volatile |
Expected Return
| 1.45 actual daily | 29 71% of assets have higher returns |
Risk-Adjusted Return
| 0.15 actual daily | 11 89% of assets perform better |
Based on monthly moving average Unity Biotechnology is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Unity Biotechnology by adding it to a well-diversified portfolio.
Price Book 4.6494 | Enterprise Value Ebitda (0.23) | Price Sales 6.5445 | Shares Float 14.9 M | Wall Street Target Price 6.6667 |
Unity Biotechnology Stock Price History Chart
There are several ways to analyze Unity Stock price data. The simplest method is using a basic Unity candlestick price chart, which shows Unity Biotechnology price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | January 23, 2025 | 2.57 |
| Lowest Price | December 20, 2024 | 0.96 |
Unity Biotechnology March 22, 2025 Stock Price Synopsis
Various analyses of Unity Biotechnology's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Unity Stock. It can be used to describe the percentage change in the price of Unity Biotechnology from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Unity Stock.| Unity Biotechnology Accumulation Distribution | 4,626 | |
| Unity Biotechnology Price Rate Of Daily Change | 1.08 | |
| Unity Biotechnology Price Action Indicator | 0.13 | |
| Unity Biotechnology Price Daily Balance Of Power | 0.81 |
Unity Biotechnology March 22, 2025 Stock Price Analysis
Unity Stock Price History Data
The price series of Unity Biotechnology for the period between Sun, Dec 22, 2024 and Sat, Mar 22, 2025 has a statistical range of 1.61 with a coefficient of variation of 25.48. The daily prices for the period are distributed with arithmetic mean of 1.7. The median price for the last 90 days is 1.75. The company experienced 1:10 stock split on 20th of October 2022.| Open | High | Low | Close | Volume | ||
| 03/21/2025 | 1.69 | 1.85 | 1.69 | 1.83 | 53,487 | |
| 03/20/2025 | 1.75 | 1.80 | 1.70 | 1.70 | 44,893 | |
| 03/19/2025 | 1.74 | 1.80 | 1.70 | 1.79 | 73,563 | |
| 03/18/2025 | 1.76 | 1.79 | 1.68 | 1.74 | 58,090 | |
| 03/17/2025 | 1.78 | 1.80 | 1.69 | 1.75 | 48,697 | |
| 03/14/2025 | 1.79 | 1.82 | 1.73 | 1.77 | 109,199 | |
| 03/13/2025 | 1.89 | 1.89 | 1.68 | 1.79 | 58,544 | |
| 03/12/2025 | 1.73 | 1.98 | 1.73 | 1.78 | 251,540 | |
| 03/11/2025 | 1.58 | 1.73 | 1.57 | 1.72 | 133,500 | |
| 03/10/2025 | 1.60 | 1.75 | 1.53 | 1.60 | 161,781 | |
| 03/07/2025 | 1.74 | 1.79 | 1.60 | 1.68 | 50,265 | |
| 03/06/2025 | 1.68 | 1.79 | 1.65 | 1.76 | 88,451 | |
| 03/05/2025 | 1.66 | 1.74 | 1.66 | 1.70 | 47,186 | |
| 03/04/2025 | 1.53 | 1.70 | 1.48 | 1.69 | 142,893 | |
| 03/03/2025 | 1.72 | 1.76 | 1.54 | 1.55 | 83,086 | |
| 02/28/2025 | 1.60 | 1.73 | 1.50 | 1.71 | 118,785 | |
| 02/27/2025 | 1.81 | 1.93 | 1.63 | 1.64 | 92,185 | |
| 02/26/2025 | 1.63 | 1.78 | 1.63 | 1.72 | 83,306 | |
| 02/25/2025 | 1.80 | 1.84 | 1.58 | 1.65 | 282,275 | |
| 02/24/2025 | 1.98 | 2.11 | 1.80 | 1.82 | 193,968 | |
| 02/21/2025 | 2.05 | 2.13 | 1.94 | 1.94 | 98,829 | |
| 02/20/2025 | 2.07 | 2.17 | 2.00 | 2.05 | 39,363 | |
| 02/19/2025 | 2.02 | 2.13 | 1.99 | 2.05 | 57,067 | |
| 02/18/2025 | 2.30 | 2.33 | 2.00 | 2.02 | 150,702 | |
| 02/14/2025 | 2.00 | 2.25 | 2.00 | 2.19 | 197,034 | |
| 02/13/2025 | 1.94 | 2.02 | 1.89 | 1.98 | 128,000 | |
| 02/12/2025 | 1.91 | 2.03 | 1.83 | 1.94 | 175,111 | |
| 02/11/2025 | 2.12 | 2.13 | 1.81 | 2.04 | 323,264 | |
| 02/10/2025 | 2.15 | 2.32 | 2.02 | 2.04 | 254,290 | |
| 02/07/2025 | 2.26 | 2.35 | 2.08 | 2.14 | 199,561 | |
| 02/06/2025 | 2.31 | 2.39 | 2.22 | 2.26 | 136,451 | |
| 02/05/2025 | 2.23 | 2.34 | 2.23 | 2.30 | 126,894 | |
| 02/04/2025 | 2.15 | 2.33 | 2.15 | 2.23 | 106,613 | |
| 02/03/2025 | 2.18 | 2.39 | 2.05 | 2.17 | 146,756 | |
| 01/31/2025 | 2.15 | 2.42 | 2.14 | 2.22 | 199,300 | |
| 01/30/2025 | 2.27 | 2.35 | 2.02 | 2.14 | 204,952 | |
| 01/29/2025 | 2.26 | 2.42 | 2.15 | 2.24 | 116,803 | |
| 01/28/2025 | 2.38 | 2.45 | 2.20 | 2.25 | 241,279 | |
| 01/27/2025 | 2.01 | 2.28 | 2.00 | 2.15 | 488,626 | |
| 01/24/2025 | 2.70 | 2.85 | 2.31 | 2.38 | 672,643 | |
| 01/23/2025 | 2.19 | 3.10 | 2.17 | 2.57 | 2,080,064 | |
| 01/22/2025 | 1.81 | 2.20 | 1.80 | 2.09 | 537,778 | |
| 01/21/2025 | 1.75 | 1.84 | 1.73 | 1.79 | 210,407 | |
| 01/17/2025 | 1.71 | 1.75 | 1.66 | 1.73 | 124,586 | |
| 01/16/2025 | 1.67 | 1.70 | 1.62 | 1.69 | 138,386 | |
| 01/15/2025 | 1.73 | 1.77 | 1.56 | 1.69 | 230,751 | |
| 01/14/2025 | 1.72 | 1.81 | 1.61 | 1.71 | 340,131 | |
| 01/13/2025 | 1.78 | 1.85 | 1.63 | 1.72 | 340,358 | |
| 01/10/2025 | 1.41 | 1.80 | 1.37 | 1.79 | 749,208 | |
| 01/08/2025 | 1.64 | 1.64 | 1.24 | 1.33 | 459,888 | |
| 01/07/2025 | 1.78 | 1.98 | 1.74 | 1.81 | 410,071 | |
| 01/06/2025 | 1.35 | 1.97 | 1.35 | 1.78 | 1,591,960 | |
| 01/03/2025 | 1.17 | 1.33 | 1.16 | 1.28 | 391,086 | |
| 01/02/2025 | 1.01 | 1.20 | 1.01 | 1.14 | 293,398 | |
| 12/31/2024 | 0.94 | 1.00 | 0.94 | 0.98 | 98,869 | |
| 12/30/2024 | 0.99 | 1.00 | 0.94 | 0.96 | 134,963 | |
| 12/27/2024 | 1.05 | 1.08 | 1.00 | 1.00 | 131,611 | |
| 12/26/2024 | 1.00 | 1.05 | 0.97 | 1.03 | 104,331 | |
| 12/24/2024 | 0.99 | 1.00 | 0.98 | 1.00 | 34,496 | |
| 12/23/2024 | 0.96 | 1.02 | 0.96 | 1.00 | 121,247 | |
| 12/20/2024 | 0.95 | 1.00 | 0.95 | 0.96 | 121,018 |
About Unity Biotechnology Stock history
Unity Biotechnology investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Unity is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Unity Biotechnology will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Unity Biotechnology stock prices may prove useful in developing a viable investing in Unity Biotechnology
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 16.8 M | 17.7 M | |
| Net Loss | -53.9 M | -56.6 M |
Unity Biotechnology Quarterly Net Working Capital |
|
Unity Biotechnology Stock Technical Analysis
Unity Biotechnology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Equity Valuation Now
Equity ValuationCheck real value of public entities based on technical and fundamental data |
| All Next | Launch Module |
Unity Biotechnology Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Unity Biotechnology's price direction in advance. Along with the technical and fundamental analysis of Unity Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Unity to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1117 | |||
| Jensen Alpha | 1.21 | |||
| Total Risk Alpha | 1.84 | |||
| Sortino Ratio | 0.1692 | |||
| Treynor Ratio | 0.5784 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Unity Stock Analysis
When running Unity Biotechnology's price analysis, check to measure Unity Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Unity Biotechnology is operating at the current time. Most of Unity Biotechnology's value examination focuses on studying past and present price action to predict the probability of Unity Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Unity Biotechnology's price. Additionally, you may evaluate how the addition of Unity Biotechnology to your portfolios can decrease your overall portfolio volatility.